Kim Ellison相关文献与解析，生知库 | 链接生命科学的每一步

Zoltan Lohinai, David Dora, Charles Caldwell, Christopher J Rivard, Kenichi Suda, Hui Yu, Gareth Rivalland, Kim Ellison, Leslie Rozeboom, Rafal Dziadziuszko, Paul Mitchell, Thomas John, Inigo S Millan, Shengxiang Ren, Fred R Hirsch

肿瘤

肺癌

其它细胞

IHC

发表日期：2022

文献求助收藏

CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer

CD44 促进肺癌获得 EGFR 激酶抑制剂耐药性时的上皮-间质转化表型变化

期刊:Molecular Cancer Therapeutics

影响因子:5.3

doi:10.1158/1535-7163.MCT-17-1279

Kenichi Suda, Isao Murakami, Hui Yu, Jihye Kim, Aik-Choon Tan, Hiroshi Mizuuchi, Leslie Rozeboom, Kim Ellison, Christopher J Rivard, Tetsuya Mitsudomi, Fred R Hirsch

Therapy-induced E-cadherin downregulation alters expression of programmed death ligand-1 in lung cancer cells

治疗诱导的 E-钙粘蛋白下调改变了肺癌细胞中程序性死亡配体-1 的表达

期刊:Lung Cancer

影响因子:4.5

doi:10.1016/j.lungcan.2017.04.010

Kenichi Suda, Leslie Rozeboom, Christopher J Rivard, Hui Yu, Kim Ellison, Mary Ann C Melnick, Trista K Hinz, Daniel Chan, Lynn E Heasley, Katerina Politi, Tetsuya Mitsudomi, Fred R Hirsch

Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status

无论 MYC 状态如何，剪接体抑制对小细胞肺癌的潜在影响

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0172209

Kenichi Suda, Leslie Rozeboom, Hui Yu, Kim Ellison, Christopher J Rivard, Tetsuya Mitsudomi, Fred R Hirsch

Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer

小细胞肺癌中的成纤维细胞生长因子受体 1 及其相关配体

期刊:Journal of Thoracic Oncology

影响因子:21

doi:10.1097/JTO.0000000000000562

Liping Zhang, Hui Yu, Andrzej Badzio, Theresa A Boyle, Hans-Ulrich Schildhaus, Xian Lu, Rafal Dziadziuszko, Jacek Jassem, Marileila Varella-Garcia, Lynn E Heasley, Ashley A Kowalewski, Kim Ellison, Gang Chen, Caicun Zhou, Fred R Hirsch

Loss of STING expression is prognostic in non-small cell lung cancer

STING 表达缺失对非小细胞肺癌具有预后意义

CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer

CD44 促进肺癌获得 EGFR 激酶抑制剂耐药性时的上皮-间质转化表型变化

Therapy-induced E-cadherin downregulation alters expression of programmed death ligand-1 in lung cancer cells

治疗诱导的 E-钙粘蛋白下调改变了肺癌细胞中程序性死亡配体-1 的表达

Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status

无论 MYC 状态如何，剪接体抑制对小细胞肺癌的潜在影响

Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer

小细胞肺癌中的成纤维细胞生长因子受体 1 及其相关配体